LA-NF-κB-ILC2轴通过促进ILC2激活在小鼠中加剧肠道牛奶蛋白过敏
Yun Zhang1, Yaling Wu1, Yingying Wang1
1Department of Pediatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, He Fei 230001, China; Graduate School, Bengbu Medical University, Bengbu 233000, China.
Cytokine
|March 4, 2026
概括
酸 (LA) 通过NF-κB通路激活2组先天性淋巴细胞 (ILC2s),加剧牛奶蛋白过敏 (CMPA). 抑制LA或这种途径可能为儿童CMPA提供新的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 分子生物学分子生物学
背景情况:
- 牛奶蛋白过敏 (CMPA) 是儿童早期流行的一种食物过敏,通常涉及2型免疫细胞,如2组先天性淋巴细胞 (ILC2).
- 利诺基酸 (LA) 是一种多不和脂肪酸,具有免疫调节特性,此前在过敏小鼠的肠道ILC2中观察到高水平.
- 对于LA在CMPA发病过程中的确切作用尚不清楚,因此需要进一步研究其对ILC2s的影响.
研究的目的:
- 在牛奶蛋白过敏 (CMPA) 的小鼠模型中研究酸 (LA) 对2组先天性淋巴细胞 (ILC2s) 激活的影响.
- 阐明LA影响ILC2激活并加剧CMPA中的过敏炎症的潜在分子机制.
主要方法:
- 从牛奶蛋白过敏和对照小鼠的肠道ILC2中定量酸 (LA) 水平.
- 流细胞计分析以评估LA对ILC2比例和IL-5/IL-13细胞因子释放的影响.
- 利用PPARα激动剂和NF-κB信号通路抑制剂,以及转录基因测序,探索免疫调节和分子通路.
主要成果:
- 与对照组相比,过敏小鼠的LA水平显著提高,ILC2比例增加,IL-5/IL-13释放量增加.
- 用PPARα激动剂治疗降低了ILC2的比例,减轻了炎症和过敏反应.
- 转录组分析表明,LA激活NF-κB信号通路;它的抑制降低了CMPA小鼠中的ILC2比例和细胞因子水平.
结论:
- 氨酸 (LA) 似乎通过NF-κB信号通路调节ILC2s来促进IL-5/IL-13的释放,并加剧CMPA中的炎症.
- 向LA积累或抑制NF-κB通路为管理幼儿CMPA提供了潜在的治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
10.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.2K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
987
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
987


